

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.78394238 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.78394238 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.53994820 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.53994820 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.51242077 |
| 6 | protein retention in ER lumen (GO:0006621) | 4.80685444 |
| 7 | glyoxylate metabolic process (GO:0046487) | 4.79864177 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.65954746 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 4.59297460 |
| 10 | bile acid biosynthetic process (GO:0006699) | 4.58930111 |
| 11 | cysteine metabolic process (GO:0006534) | 4.53407066 |
| 12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.51080255 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 4.44399549 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.40971329 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.40971329 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.40971329 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.29721298 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.26566176 |
| 19 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.25200533 |
| 20 | protein maturation by protein folding (GO:0022417) | 4.18040407 |
| 21 | tryptophan metabolic process (GO:0006568) | 4.14332036 |
| 22 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.07262530 |
| 23 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.07262530 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 4.06387101 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 4.05998913 |
| 26 | fatty acid elongation (GO:0030497) | 4.05079761 |
| 27 | aromatic amino acid family metabolic process (GO:0009072) | 4.00674624 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.99928538 |
| 29 | protein carboxylation (GO:0018214) | 3.99928538 |
| 30 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.95545839 |
| 31 | coenzyme catabolic process (GO:0009109) | 3.93805130 |
| 32 | bile acid metabolic process (GO:0008206) | 3.93584856 |
| 33 | plasma lipoprotein particle assembly (GO:0034377) | 3.91008026 |
| 34 | lysine catabolic process (GO:0006554) | 3.90022784 |
| 35 | lysine metabolic process (GO:0006553) | 3.90022784 |
| 36 | short-chain fatty acid metabolic process (GO:0046459) | 3.89104126 |
| 37 | protein-lipid complex assembly (GO:0065005) | 3.88502573 |
| 38 | proline biosynthetic process (GO:0006561) | 3.84975298 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 3.84080162 |
| 40 | heme transport (GO:0015886) | 3.82764768 |
| 41 | tyrosine metabolic process (GO:0006570) | 3.80599395 |
| 42 | very long-chain fatty acid metabolic process (GO:0000038) | 3.77698755 |
| 43 | urea cycle (GO:0000050) | 3.77504659 |
| 44 | urea metabolic process (GO:0019627) | 3.77504659 |
| 45 | negative regulation of fibrinolysis (GO:0051918) | 3.77244929 |
| 46 | acetyl-CoA metabolic process (GO:0006084) | 3.76924087 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 3.75384916 |
| 48 | triglyceride homeostasis (GO:0070328) | 3.73362776 |
| 49 | acylglycerol homeostasis (GO:0055090) | 3.73362776 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 3.70102232 |
| 51 | complement activation, alternative pathway (GO:0006957) | 3.68648024 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 3.67039631 |
| 53 | ethanol oxidation (GO:0006069) | 3.65603981 |
| 54 | proline metabolic process (GO:0006560) | 3.64186383 |
| 55 | nitrogen cycle metabolic process (GO:0071941) | 3.63451389 |
| 56 | GDP-mannose metabolic process (GO:0019673) | 3.61367388 |
| 57 | regulation of fibrinolysis (GO:0051917) | 3.60426915 |
| 58 | cofactor catabolic process (GO:0051187) | 3.59985155 |
| 59 | Golgi transport vesicle coating (GO:0048200) | 3.59754848 |
| 60 | COPI coating of Golgi vesicle (GO:0048205) | 3.59754848 |
| 61 | aspartate family amino acid catabolic process (GO:0009068) | 3.58554922 |
| 62 | ribosomal small subunit biogenesis (GO:0042274) | 3.57880708 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 3.56660894 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 3.56401408 |
| 65 | serine family amino acid catabolic process (GO:0009071) | 3.53743995 |
| 66 | homocysteine metabolic process (GO:0050667) | 3.52673436 |
| 67 | fatty acid catabolic process (GO:0009062) | 3.51140946 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.50743334 |
| 69 | regulation of protein activation cascade (GO:2000257) | 3.49358361 |
| 70 | aldehyde catabolic process (GO:0046185) | 3.48778861 |
| 71 | regulation of cholesterol homeostasis (GO:2000188) | 3.46673641 |
| 72 | reverse cholesterol transport (GO:0043691) | 3.46045318 |
| 73 | plasma lipoprotein particle remodeling (GO:0034369) | 3.45731145 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 3.45731145 |
| 75 | macromolecular complex remodeling (GO:0034367) | 3.45731145 |
| 76 | drug transmembrane transport (GO:0006855) | 3.45182367 |
| 77 | 4-hydroxyproline metabolic process (GO:0019471) | 3.45110052 |
| 78 | fatty acid oxidation (GO:0019395) | 3.44145150 |
| 79 | response to mercury ion (GO:0046689) | 3.39549245 |
| 80 | low-density lipoprotein particle clearance (GO:0034383) | 3.39357946 |
| 81 | lipid oxidation (GO:0034440) | 3.37282258 |
| 82 | monocarboxylic acid catabolic process (GO:0072329) | 3.36645227 |
| 83 | protein localization to endosome (GO:0036010) | 3.36562254 |
| 84 | glucose 6-phosphate metabolic process (GO:0051156) | 3.35954333 |
| 85 | regulation of cholesterol metabolic process (GO:0090181) | 3.35952095 |
| 86 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.35324852 |
| 87 | ketone body metabolic process (GO:1902224) | 3.35131565 |
| 88 | oligosaccharide catabolic process (GO:0009313) | 3.34796066 |
| 89 | bile acid and bile salt transport (GO:0015721) | 3.32674554 |
| 90 | phospholipid efflux (GO:0033700) | 3.32117794 |
| 91 | organic acid catabolic process (GO:0016054) | 3.31355463 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.31355463 |
| 93 | glutamate metabolic process (GO:0006536) | 3.30805229 |
| 94 | regulation of complement activation (GO:0030449) | 3.26973458 |
| 95 | glycosphingolipid catabolic process (GO:0046479) | 3.26875519 |
| 96 | amine catabolic process (GO:0009310) | 3.26496319 |
| 97 | cellular biogenic amine catabolic process (GO:0042402) | 3.26496319 |
| 98 | negative regulation of cholesterol transport (GO:0032375) | 3.24989028 |
| 99 | negative regulation of sterol transport (GO:0032372) | 3.24989028 |
| 100 | cholesterol efflux (GO:0033344) | 3.24897412 |
| 101 | benzene-containing compound metabolic process (GO:0042537) | 3.24759129 |
| 102 | cellular modified amino acid catabolic process (GO:0042219) | 3.24610793 |
| 103 | thioester metabolic process (GO:0035383) | 3.23727159 |
| 104 | acyl-CoA metabolic process (GO:0006637) | 3.23727159 |
| 105 | regulation of superoxide anion generation (GO:0032928) | 3.22787065 |
| 106 | serine family amino acid metabolic process (GO:0009069) | 3.22648608 |
| 107 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.21874615 |
| 108 | serine family amino acid biosynthetic process (GO:0009070) | 3.21425022 |
| 109 | branched-chain amino acid catabolic process (GO:0009083) | 3.18021618 |
| 110 | indolalkylamine metabolic process (GO:0006586) | 3.17599490 |
| 111 | regulation of early endosome to late endosome transport (GO:2000641) | 3.16989362 |
| 112 | acyl-CoA biosynthetic process (GO:0071616) | 3.16825971 |
| 113 | thioester biosynthetic process (GO:0035384) | 3.16825971 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.16742974 |
| 115 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.16735616 |
| 116 | sterol homeostasis (GO:0055092) | 3.10688450 |
| 117 | creatine metabolic process (GO:0006600) | 3.10613713 |
| 118 | adhesion of symbiont to host (GO:0044406) | 3.10309357 |
| 119 | cellular glucuronidation (GO:0052695) | 3.09948566 |
| 120 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.09535332 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.08585708 |
| 122 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.08312624 |
| 123 | valine metabolic process (GO:0006573) | 3.08191328 |
| 124 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.06608153 |
| 125 | regulation of cholesterol storage (GO:0010885) | 3.05625805 |
| 126 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.99360006 |
| 127 | cellular copper ion homeostasis (GO:0006878) | 2.96861479 |
| 128 | UV protection (GO:0009650) | 2.94052387 |
| 129 | glycolipid catabolic process (GO:0019377) | 2.93159940 |
| 130 | serine transport (GO:0032329) | 2.90223876 |
| 131 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.89431854 |
| 132 | pentose metabolic process (GO:0019321) | 2.89423343 |
| 133 | low-density lipoprotein particle remodeling (GO:0034374) | 2.89133137 |
| 134 | regulation of apoptotic cell clearance (GO:2000425) | 2.87711597 |
| 135 | NADH metabolic process (GO:0006734) | 2.83454033 |
| 136 | protein-lipid complex subunit organization (GO:0071825) | 2.82454977 |
| 137 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.81994722 |
| 138 | pinocytosis (GO:0006907) | 2.79188356 |
| 139 | plasma lipoprotein particle organization (GO:0071827) | 2.76906334 |
| 140 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.76218961 |
| 141 | barbed-end actin filament capping (GO:0051016) | 2.72974400 |
| 142 | protein insertion into membrane (GO:0051205) | 2.72410069 |
| 143 | amyloid precursor protein catabolic process (GO:0042987) | 2.69698509 |
| 144 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.69413763 |
| 145 | positive regulation of extracellular matrix organization (GO:1903055) | 2.69274825 |
| 146 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.65160158 |
| 147 | activation of MAPKKK activity (GO:0000185) | 2.63013307 |
| 148 | glucose catabolic process (GO:0006007) | 2.62243818 |
| 149 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.62172701 |
| 150 | modulation by symbiont of host cellular process (GO:0044068) | 2.61925531 |
| 151 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.61212784 |
| 152 | glutathione biosynthetic process (GO:0006750) | 2.60731719 |
| 153 | peptidyl-proline hydroxylation (GO:0019511) | 2.60226918 |
| 154 | pentose-phosphate shunt (GO:0006098) | 2.58942465 |
| 155 | cell-cell junction maintenance (GO:0045217) | 2.58653376 |
| 156 | response to thyroid hormone (GO:0097066) | 2.56407650 |
| 157 | acute-phase response (GO:0006953) | 2.55845110 |
| 158 | fibrinolysis (GO:0042730) | 2.53241169 |
| 159 | adhesion of symbiont to host cell (GO:0044650) | 2.53068869 |
| 160 | virion attachment to host cell (GO:0019062) | 2.53068869 |
| 161 | regulation of plasminogen activation (GO:0010755) | 2.52946160 |
| 162 | monosaccharide biosynthetic process (GO:0046364) | 2.52572484 |
| 163 | positive regulation of nuclease activity (GO:0032075) | 2.51299741 |
| 164 | amino sugar catabolic process (GO:0046348) | 2.51171551 |
| 165 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51096271 |
| 166 | L-serine transport (GO:0015825) | 2.50553066 |
| 167 | apoptotic process involved in morphogenesis (GO:0060561) | 2.50303892 |
| 168 | basement membrane organization (GO:0071711) | 2.48447792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.88729190 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.39033758 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.45616733 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.37492826 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.93904867 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.75094067 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.48551192 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.17044526 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.05998404 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.16680369 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.82441607 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.79691445 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.45604640 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27661101 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20127032 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.08020211 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96567732 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90718146 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.76606384 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75281869 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72317440 |
| 22 | P68_20966046_ChIP-Seq_HELA_Human | 1.71836476 |
| 23 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.71238741 |
| 24 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.58032297 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.57675376 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57080299 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.55152827 |
| 28 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54932928 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53740044 |
| 30 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53127827 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51836177 |
| 32 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.49735072 |
| 33 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49646851 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48255324 |
| 35 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47650461 |
| 36 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.47457137 |
| 37 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.46632755 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.45398990 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44422244 |
| 40 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43461655 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41881629 |
| 42 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.39905888 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39512965 |
| 44 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36227305 |
| 45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.35850240 |
| 46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35159605 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33063308 |
| 48 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31245047 |
| 49 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30100116 |
| 50 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29259085 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29178923 |
| 52 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.28903845 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25092944 |
| 54 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.23943462 |
| 55 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23444684 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22436012 |
| 57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22175827 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21692134 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20683729 |
| 60 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.19723142 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19619776 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19479355 |
| 63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19164406 |
| 64 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.18989766 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18826460 |
| 66 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18334298 |
| 67 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.17926361 |
| 68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14528241 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14513508 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13307451 |
| 71 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.12025217 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11042187 |
| 73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10723414 |
| 74 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09621831 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09576123 |
| 76 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09204880 |
| 77 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08742620 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08514400 |
| 79 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.06353377 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05294115 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05222967 |
| 82 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04819294 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03988941 |
| 84 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03874996 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03825880 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03281293 |
| 87 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.02854765 |
| 88 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.02816521 |
| 89 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.02319482 |
| 90 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.02229381 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02219710 |
| 92 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02078164 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99531525 |
| 94 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.99440950 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99016631 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97657071 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97335719 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96468617 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95667496 |
| 100 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.95654236 |
| 101 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94946749 |
| 102 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92065052 |
| 103 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90675577 |
| 104 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90537916 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90381382 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90275683 |
| 107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90097813 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86574736 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83927296 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83927296 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82215645 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81522827 |
| 113 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80644985 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77656926 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75506320 |
| 116 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.74691989 |
| 117 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.74440947 |
| 118 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.74110670 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74043015 |
| 120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73943610 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72822160 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72284503 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72154782 |
| 124 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.72118619 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71526890 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71168244 |
| 127 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.71128567 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69650823 |
| 129 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.69626704 |
| 130 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.69304440 |
| 131 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.68764354 |
| 132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.68127254 |
| 133 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66726323 |
| 134 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.66675928 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66511490 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.66222810 |
| 137 | SA1_27219007_Chip-Seq_Bcells_Human | 0.65582291 |
| 138 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.64978194 |
| 139 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64930306 |
| 140 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64915911 |
| 141 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64908718 |
| 142 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.64848975 |
| 143 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.63874909 |
| 144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63855943 |
| 145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.63787253 |
| 146 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62766612 |
| 147 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62560924 |
| 148 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.62535680 |
| 149 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.62455654 |
| 150 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.62298413 |
| 151 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61762775 |
| 152 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.61601274 |
| 153 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.61517577 |
| 154 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.61194685 |
| 155 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.60851973 |
| 156 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60430859 |
| 157 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.59262725 |
| 158 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.58838464 |
| 159 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58784000 |
| 160 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.58773358 |
| 161 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.58295774 |
| 162 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.57992296 |
| 163 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57889095 |
| 164 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.56763443 |
| 165 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56574111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.70847193 |
| 2 | MP0005360_urolithiasis | 5.94307689 |
| 3 | MP0005365_abnormal_bile_salt | 5.12177048 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.74411969 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.26108525 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.99732769 |
| 7 | MP0008260_abnormal_autophagy | 3.30763808 |
| 8 | MP0009840_abnormal_foam_cell | 3.27357903 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 3.22024284 |
| 10 | MP0003195_calcinosis | 2.99406630 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.98269020 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.96431335 |
| 13 | MP0005332_abnormal_amino_acid | 2.85964967 |
| 14 | MP0005083_abnormal_biliary_tract | 2.80903823 |
| 15 | MP0003252_abnormal_bile_duct | 2.77992959 |
| 16 | MP0000678_abnormal_parathyroid_gland | 2.71858956 |
| 17 | MP0003123_paternal_imprinting | 2.45440224 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.40896477 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.13050561 |
| 20 | MP0004858_abnormal_nervous_system | 2.05037751 |
| 21 | MP0005451_abnormal_body_composition | 2.03548164 |
| 22 | MP0003329_amyloid_beta_deposits | 1.86736721 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 1.85060792 |
| 24 | MP0003453_abnormal_keratinocyte_physiol | 1.84643782 |
| 25 | MP0000609_abnormal_liver_physiology | 1.79473297 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.77936792 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.75492681 |
| 28 | MP0004510_myositis | 1.75192885 |
| 29 | MP0000920_abnormal_myelination | 1.68694854 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.68075174 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.65427466 |
| 32 | MP0000604_amyloidosis | 1.65133349 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.64596561 |
| 34 | MP0003186_abnormal_redox_activity | 1.60365208 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.57423587 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.55672909 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.52053440 |
| 38 | MP0003436_decreased_susceptibility_to | 1.51861823 |
| 39 | MP0003879_abnormal_hair_cell | 1.50711117 |
| 40 | MP0004043_abnormal_pH_regulation | 1.48459637 |
| 41 | MP0003303_peritoneal_inflammation | 1.45883537 |
| 42 | MP0001764_abnormal_homeostasis | 1.44715071 |
| 43 | MP0005410_abnormal_fertilization | 1.43747531 |
| 44 | MP0000858_altered_metastatic_potential | 1.43538734 |
| 45 | MP0001849_ear_inflammation | 1.41957907 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.41292533 |
| 47 | MP0003690_abnormal_glial_cell | 1.41235587 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.36422837 |
| 49 | MP0000681_abnormal_thyroid_gland | 1.35975057 |
| 50 | MP0003011_delayed_dark_adaptation | 1.33476463 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.30476513 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.28191628 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.26940360 |
| 54 | MP0003868_abnormal_feces_composition | 1.26695808 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.26378526 |
| 56 | MP0005501_abnormal_skin_physiology | 1.24204725 |
| 57 | MP0005670_abnormal_white_adipose | 1.20842310 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.20550392 |
| 59 | MP0002249_abnormal_larynx_morphology | 1.15907432 |
| 60 | MP0000003_abnormal_adipose_tissue | 1.12514262 |
| 61 | MP0001853_heart_inflammation | 1.09946295 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.06879002 |
| 63 | MP0000343_altered_response_to | 1.05461184 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.04346678 |
| 65 | MP0004233_abnormal_muscle_weight | 1.04203635 |
| 66 | MP0004130_abnormal_muscle_cell | 0.97796372 |
| 67 | MP0009278_abnormal_bone_marrow | 0.96282113 |
| 68 | MP0005023_abnormal_wound_healing | 0.96044524 |
| 69 | MP0005166_decreased_susceptibility_to | 0.95711789 |
| 70 | MP0008469_abnormal_protein_level | 0.95510802 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 0.94480111 |
| 72 | MP0001661_extended_life_span | 0.94459249 |
| 73 | MP0002876_abnormal_thyroid_physiology | 0.93411541 |
| 74 | MP0005535_abnormal_body_temperature | 0.92898613 |
| 75 | MP0001915_intracranial_hemorrhage | 0.92112106 |
| 76 | MP0005408_hypopigmentation | 0.91850821 |
| 77 | MP0001756_abnormal_urination | 0.91809314 |
| 78 | MP0004147_increased_porphyrin_level | 0.90361503 |
| 79 | MP0005647_abnormal_sex_gland | 0.90254101 |
| 80 | MP0003724_increased_susceptibility_to | 0.90099699 |
| 81 | MP0005623_abnormal_meninges_morphology | 0.89912982 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.89584828 |
| 83 | MP0000566_synostosis | 0.88005069 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.87620051 |
| 85 | MP0000598_abnormal_liver_morphology | 0.86780853 |
| 86 | MP0004859_abnormal_synaptic_plasticity | 0.86548816 |
| 87 | MP0002971_abnormal_brown_adipose | 0.83965414 |
| 88 | MP0004947_skin_inflammation | 0.83641795 |
| 89 | MP0000747_muscle_weakness | 0.82446783 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.82367789 |
| 91 | MP0009763_increased_sensitivity_to | 0.82093880 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.81898092 |
| 93 | MP0003122_maternal_imprinting | 0.81379915 |
| 94 | MP0002132_abnormal_respiratory_system | 0.80871068 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.80011603 |
| 96 | MP0009764_decreased_sensitivity_to | 0.76473701 |
| 97 | MP0005409_darkened_coat_color | 0.74811342 |
| 98 | MP0006082_CNS_inflammation | 0.73976695 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.72862593 |
| 100 | MP0001730_embryonic_growth_arrest | 0.72828486 |
| 101 | MP0001765_abnormal_ion_homeostasis | 0.72232314 |
| 102 | MP0005220_abnormal_exocrine_pancreas | 0.70239045 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.70203292 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.68988909 |
| 105 | MP0004381_abnormal_hair_follicle | 0.68543547 |
| 106 | MP0005334_abnormal_fat_pad | 0.68225965 |
| 107 | MP0004272_abnormal_basement_membrane | 0.67633747 |
| 108 | MP0004264_abnormal_extraembryonic_tissu | 0.67307052 |
| 109 | MP0009697_abnormal_copulation | 0.66555838 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.66274523 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.65242586 |
| 112 | MP0003075_altered_response_to | 0.64652184 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.64649388 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.63788180 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 0.63718227 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.63718227 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.62337779 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.61749356 |
| 119 | MP0009785_altered_susceptibility_to | 0.60479821 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.59968822 |
| 121 | MP0005025_abnormal_response_to | 0.58133533 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.57436807 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.57435900 |
| 124 | MP0002229_neurodegeneration | 0.57425759 |
| 125 | MP0005375_adipose_tissue_phenotype | 0.55645662 |
| 126 | MP0004036_abnormal_muscle_relaxation | 0.55640897 |
| 127 | MP0002148_abnormal_hypersensitivity_rea | 0.55573534 |
| 128 | MP0000749_muscle_degeneration | 0.54571478 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.54267037 |
| 130 | MP0000537_abnormal_urethra_morphology | 0.54095384 |
| 131 | MP0005448_abnormal_energy_balance | 0.53180969 |
| 132 | MP0004142_abnormal_muscle_tone | 0.52522382 |
| 133 | MP0002822_catalepsy | 0.51850688 |
| 134 | MP0005266_abnormal_metabolism | 0.51727435 |
| 135 | MP0004782_abnormal_surfactant_physiolog | 0.51668781 |
| 136 | MP0008873_increased_physiological_sensi | 0.51218268 |
| 137 | MP0002090_abnormal_vision | 0.50465737 |
| 138 | MP0008874_decreased_physiological_sensi | 0.50249141 |
| 139 | MP0003315_abnormal_perineum_morphology | 0.50139037 |
| 140 | MP0003950_abnormal_plasma_membrane | 0.50079731 |
| 141 | MP0005330_cardiomyopathy | 0.49362517 |
| 142 | MP0001905_abnormal_dopamine_level | 0.47819755 |
| 143 | MP0005551_abnormal_eye_electrophysiolog | 0.47130379 |
| 144 | MP0003632_abnormal_nervous_system | 0.46075747 |
| 145 | MP0003634_abnormal_glial_cell | 0.45760567 |
| 146 | MP0003953_abnormal_hormone_level | 0.45217058 |
| 147 | MP0003633_abnormal_nervous_system | 0.44689061 |
| 148 | MP0005464_abnormal_platelet_physiology | 0.44594588 |
| 149 | MP0002796_impaired_skin_barrier | 0.43858211 |
| 150 | MP0003959_abnormal_lean_body | 0.43163678 |
| 151 | MP0005165_increased_susceptibility_to | 0.41051544 |
| 152 | MP0010368_abnormal_lymphatic_system | 0.40641093 |
| 153 | MP0003631_nervous_system_phenotype | 0.40032483 |
| 154 | MP0000249_abnormal_blood_vessel | 0.38831595 |
| 155 | MP0005595_abnormal_vascular_smooth | 0.38362403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.43563185 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.27357808 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.00657778 |
| 4 | Xanthomatosis (HP:0000991) | 4.87426604 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.49961562 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.44384292 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.35864103 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.09366268 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.09366268 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.09366268 |
| 11 | Ketosis (HP:0001946) | 3.98344556 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.98213989 |
| 13 | Hyperammonemia (HP:0001987) | 3.82872765 |
| 14 | Complement deficiency (HP:0004431) | 3.80434001 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 3.71292121 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.71292121 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.66757138 |
| 18 | Hyperglycinuria (HP:0003108) | 3.54907489 |
| 19 | Hyperglycinemia (HP:0002154) | 3.48473305 |
| 20 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.45020609 |
| 21 | Vertebral compression fractures (HP:0002953) | 3.40371928 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.38600342 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.28243605 |
| 24 | Fat malabsorption (HP:0002630) | 3.27285841 |
| 25 | Ketoacidosis (HP:0001993) | 3.21129500 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.20811718 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.15777395 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.15555886 |
| 29 | Dysostosis multiplex (HP:0000943) | 3.13984050 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.12645214 |
| 31 | Joint hemorrhage (HP:0005261) | 3.09661549 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.08692344 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.01006371 |
| 34 | Abnormality of the Achilles tendon (HP:0005109) | 3.00769734 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 2.97001104 |
| 36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.97001104 |
| 37 | Cerebral edema (HP:0002181) | 2.87604084 |
| 38 | Achilles tendon contracture (HP:0001771) | 2.86558185 |
| 39 | Nuclear cataract (HP:0100018) | 2.82985078 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.81432471 |
| 41 | Lethargy (HP:0001254) | 2.77190898 |
| 42 | Steatorrhea (HP:0002570) | 2.76657544 |
| 43 | Gout (HP:0001997) | 2.75939652 |
| 44 | Purpura (HP:0000979) | 2.73446770 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.71465781 |
| 46 | Metabolic acidosis (HP:0001942) | 2.70575871 |
| 47 | Epidermoid cyst (HP:0200040) | 2.70564128 |
| 48 | Conjugated hyperbilirubinemia (HP:0002908) | 2.69398760 |
| 49 | Loss of speech (HP:0002371) | 2.69013295 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.68356409 |
| 51 | Hepatic necrosis (HP:0002605) | 2.68170978 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.67752349 |
| 53 | Abnormality of complement system (HP:0005339) | 2.60339320 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.59855383 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.59828396 |
| 56 | Hyperbilirubinemia (HP:0002904) | 2.59581334 |
| 57 | Prolonged neonatal jaundice (HP:0006579) | 2.55410636 |
| 58 | Acute encephalopathy (HP:0006846) | 2.54060544 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.52064324 |
| 60 | Upper limb amyotrophy (HP:0009129) | 2.45907119 |
| 61 | Distal upper limb amyotrophy (HP:0007149) | 2.45907119 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.44487265 |
| 63 | Alkalosis (HP:0001948) | 2.44283417 |
| 64 | Axonal loss (HP:0003447) | 2.43917738 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.43874346 |
| 66 | Hyperacusis (HP:0010780) | 2.41242545 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.40153415 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40153415 |
| 69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40024768 |
| 70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40024768 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40024768 |
| 72 | Vomiting (HP:0002013) | 2.38337819 |
| 73 | Hypercholesterolemia (HP:0003124) | 2.37936265 |
| 74 | Increased cerebral lipofuscin (HP:0011813) | 2.37088743 |
| 75 | Glycosuria (HP:0003076) | 2.36791654 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 2.36791654 |
| 77 | Personality changes (HP:0000751) | 2.35785732 |
| 78 | Hepatocellular necrosis (HP:0001404) | 2.33741018 |
| 79 | Neuronal loss in central nervous system (HP:0002529) | 2.32105693 |
| 80 | Vascular calcification (HP:0004934) | 2.31717772 |
| 81 | Abnormal gallbladder physiology (HP:0012438) | 2.30911756 |
| 82 | Cholecystitis (HP:0001082) | 2.30911756 |
| 83 | Spastic paraparesis (HP:0002313) | 2.30269542 |
| 84 | Amyloidosis (HP:0011034) | 2.29505854 |
| 85 | Abnormal gallbladder morphology (HP:0012437) | 2.28879854 |
| 86 | Abnormality of nucleobase metabolism (HP:0010932) | 2.26708516 |
| 87 | Irritability (HP:0000737) | 2.23573309 |
| 88 | Increased muscle lipid content (HP:0009058) | 2.22549950 |
| 89 | Parakeratosis (HP:0001036) | 2.20291170 |
| 90 | Hand muscle atrophy (HP:0009130) | 2.18829433 |
| 91 | Ragged-red muscle fibers (HP:0003200) | 2.18747867 |
| 92 | Upper motor neuron abnormality (HP:0002127) | 2.18476072 |
| 93 | Insomnia (HP:0100785) | 2.16701028 |
| 94 | Cholelithiasis (HP:0001081) | 2.16064560 |
| 95 | Brushfield spots (HP:0001088) | 2.15576352 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.13781469 |
| 97 | Methylmalonic aciduria (HP:0012120) | 2.11838314 |
| 98 | Late onset (HP:0003584) | 2.09791400 |
| 99 | Dementia (HP:0000726) | 2.08958396 |
| 100 | Flat acetabular roof (HP:0003180) | 2.08649242 |
| 101 | Cerebral hemorrhage (HP:0001342) | 2.08525254 |
| 102 | Progressive neurologic deterioration (HP:0002344) | 2.08235485 |
| 103 | Opisthotonus (HP:0002179) | 2.06710320 |
| 104 | Pancreatitis (HP:0001733) | 2.06477227 |
| 105 | Hypokalemic alkalosis (HP:0001949) | 2.06229032 |
| 106 | Vacuolated lymphocytes (HP:0001922) | 2.05314886 |
| 107 | Glomerulonephritis (HP:0000099) | 2.03831229 |
| 108 | Multiple enchondromatosis (HP:0005701) | 2.01494188 |
| 109 | Reticulocytosis (HP:0001923) | 2.00787769 |
| 110 | Hyperparathyroidism (HP:0000843) | 2.00069702 |
| 111 | Cardiovascular calcification (HP:0011915) | 1.99352227 |
| 112 | Abnormality of glycolysis (HP:0004366) | 1.98842303 |
| 113 | Increased serum pyruvate (HP:0003542) | 1.98842303 |
| 114 | Apathy (HP:0000741) | 1.98655211 |
| 115 | Increased serum ferritin (HP:0003281) | 1.95912732 |
| 116 | Athetosis (HP:0002305) | 1.95362058 |
| 117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94538129 |
| 118 | Methylmalonic acidemia (HP:0002912) | 1.94446131 |
| 119 | Hypoglycemic seizures (HP:0002173) | 1.93667225 |
| 120 | Skin nodule (HP:0200036) | 1.93261912 |
| 121 | Abnormality of carpal bone ossification (HP:0006257) | 1.92467952 |
| 122 | Sensorimotor neuropathy (HP:0007141) | 1.92292473 |
| 123 | Hypokinesia (HP:0002375) | 1.91667413 |
| 124 | Increased intramyocellular lipid droplets (HP:0012240) | 1.91591494 |
| 125 | Cerebral inclusion bodies (HP:0100314) | 1.91313220 |
| 126 | Diminished motivation (HP:0000745) | 1.91251502 |
| 127 | Polygenic inheritance (HP:0010982) | 1.91030287 |
| 128 | Proximal tubulopathy (HP:0000114) | 1.90718796 |
| 129 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90216159 |
| 130 | Hyperthyroidism (HP:0000836) | 1.88311911 |
| 131 | Asymmetric septal hypertrophy (HP:0001670) | 1.87786792 |
| 132 | Abnormality of iron homeostasis (HP:0011031) | 1.87534816 |
| 133 | Renal Fanconi syndrome (HP:0001994) | 1.86376235 |
| 134 | Myocardial infarction (HP:0001658) | 1.84080920 |
| 135 | Myoglobinuria (HP:0002913) | 1.83984764 |
| 136 | Malnutrition (HP:0004395) | 1.83148816 |
| 137 | Hyperuricemia (HP:0002149) | 1.82654451 |
| 138 | Increased purine levels (HP:0004368) | 1.82654451 |
| 139 | Abnormality of the gallbladder (HP:0005264) | 1.82267369 |
| 140 | Paraparesis (HP:0002385) | 1.82044653 |
| 141 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.81865968 |
| 142 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81857322 |
| 143 | Acute necrotizing encephalopathy (HP:0006965) | 1.81840529 |
| 144 | Mitochondrial inheritance (HP:0001427) | 1.79708062 |
| 145 | Diaphragmatic weakness (HP:0009113) | 1.79627042 |
| 146 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79435925 |
| 147 | Progressive muscle weakness (HP:0003323) | 1.79330436 |
| 148 | Back pain (HP:0003418) | 1.79121067 |
| 149 | Abnormality of the thoracic spine (HP:0100711) | 1.78878495 |
| 150 | Myokymia (HP:0002411) | 1.77698159 |
| 151 | Growth hormone excess (HP:0000845) | 1.77685923 |
| 152 | Protrusio acetabuli (HP:0003179) | 1.75846041 |
| 153 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.74507608 |
| 154 | Pathologic fracture (HP:0002756) | 1.73137064 |
| 155 | Elevated alkaline phosphatase (HP:0003155) | 1.72087284 |
| 156 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.71729031 |
| 157 | Retinal atrophy (HP:0001105) | 1.70572980 |
| 158 | Thoracic kyphosis (HP:0002942) | 1.69975207 |
| 159 | Neonatal death (HP:0003811) | 1.67633437 |
| 160 | Hypertriglyceridemia (HP:0002155) | 1.67288534 |
| 161 | Abnormal tarsal ossification (HP:0008369) | 1.67161947 |
| 162 | Delusions (HP:0000746) | 1.66254936 |
| 163 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.65667082 |
| 164 | Fasciculations (HP:0002380) | 1.65645090 |
| 165 | Atelectasis (HP:0100750) | 1.65329192 |
| 166 | Myopathic facies (HP:0002058) | 1.63395175 |
| 167 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.62056308 |
| 168 | Stridor (HP:0010307) | 1.61033295 |
| 169 | Distal lower limb muscle weakness (HP:0009053) | 1.59869895 |
| 170 | Nephritis (HP:0000123) | 1.59193033 |
| 171 | Abnormality of macrophages (HP:0004311) | 1.59160798 |
| 172 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.57314505 |
| 173 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.57314505 |
| 174 | Short nail (HP:0001799) | 1.56643215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.61030044 |
| 2 | STK39 | 3.66813703 |
| 3 | OXSR1 | 3.44342745 |
| 4 | IRAK3 | 3.20997143 |
| 5 | EPHB1 | 3.15643530 |
| 6 | TESK1 | 3.12704573 |
| 7 | SMG1 | 2.90127033 |
| 8 | ERN1 | 2.86645118 |
| 9 | WNK4 | 2.58317286 |
| 10 | RIPK1 | 2.51997438 |
| 11 | SIK1 | 2.33948868 |
| 12 | FGFR4 | 2.23540854 |
| 13 | MAPK15 | 2.17415421 |
| 14 | EPHA2 | 2.14391414 |
| 15 | MUSK | 2.11426432 |
| 16 | PIM2 | 2.04220855 |
| 17 | PIK3CG | 1.95867629 |
| 18 | CDK12 | 1.83891226 |
| 19 | PRPF4B | 1.83210535 |
| 20 | MET | 1.75784180 |
| 21 | TAOK2 | 1.66838048 |
| 22 | DDR2 | 1.66381517 |
| 23 | TAOK3 | 1.63518715 |
| 24 | INSRR | 1.62985741 |
| 25 | PKN1 | 1.57522129 |
| 26 | EEF2K | 1.47851136 |
| 27 | PRKD3 | 1.46015016 |
| 28 | TYRO3 | 1.38508879 |
| 29 | CDK19 | 1.35458415 |
| 30 | MST1R | 1.29583420 |
| 31 | BRAF | 1.27017259 |
| 32 | TRIB3 | 1.23509120 |
| 33 | PBK | 1.22986294 |
| 34 | LATS2 | 1.21301190 |
| 35 | TAOK1 | 1.17452542 |
| 36 | MAPKAPK5 | 1.15931632 |
| 37 | CAMK2G | 1.14959081 |
| 38 | MAP2K2 | 1.13331011 |
| 39 | PIK3CA | 1.12574206 |
| 40 | TIE1 | 1.12540249 |
| 41 | PHKG1 | 1.09175814 |
| 42 | PHKG2 | 1.09175814 |
| 43 | MAPKAPK3 | 1.08490176 |
| 44 | MAP3K3 | 1.05407539 |
| 45 | STK16 | 1.04394591 |
| 46 | MYLK | 1.04200999 |
| 47 | MAP3K13 | 1.04138648 |
| 48 | NME2 | 1.00813978 |
| 49 | PAK4 | 1.00397254 |
| 50 | TBK1 | 1.00089162 |
| 51 | PINK1 | 0.99999907 |
| 52 | FGFR2 | 0.98434879 |
| 53 | TYK2 | 0.98125311 |
| 54 | TGFBR2 | 0.97633490 |
| 55 | TESK2 | 0.96900194 |
| 56 | BCR | 0.96328399 |
| 57 | PDGFRA | 0.95742926 |
| 58 | CAMK2D | 0.95417243 |
| 59 | ABL2 | 0.94223757 |
| 60 | IRAK1 | 0.93943678 |
| 61 | MAP3K11 | 0.93115548 |
| 62 | MST4 | 0.92148653 |
| 63 | MAP2K3 | 0.90573372 |
| 64 | CSNK1G3 | 0.89949915 |
| 65 | FLT3 | 0.89055851 |
| 66 | MAP3K1 | 0.88632250 |
| 67 | KDR | 0.88253379 |
| 68 | SIK2 | 0.86482799 |
| 69 | CAMK2B | 0.85886231 |
| 70 | DAPK1 | 0.85085757 |
| 71 | KSR2 | 0.84457404 |
| 72 | CSNK1G1 | 0.83692079 |
| 73 | AURKA | 0.81788972 |
| 74 | PDPK1 | 0.80104193 |
| 75 | VRK2 | 0.79191066 |
| 76 | MAP4K1 | 0.79033760 |
| 77 | CDK11A | 0.78392428 |
| 78 | SCYL2 | 0.78028321 |
| 79 | DAPK2 | 0.77101112 |
| 80 | OBSCN | 0.76943120 |
| 81 | CSF1R | 0.76690620 |
| 82 | IRAK2 | 0.75950096 |
| 83 | SGK494 | 0.75299603 |
| 84 | SGK223 | 0.75299603 |
| 85 | NTRK1 | 0.73259923 |
| 86 | CDC42BPA | 0.73043219 |
| 87 | DAPK3 | 0.72777261 |
| 88 | GRK1 | 0.72482751 |
| 89 | MAP3K7 | 0.71802197 |
| 90 | PTK6 | 0.71083992 |
| 91 | CDK7 | 0.71040520 |
| 92 | GSK3A | 0.69594158 |
| 93 | MARK2 | 0.68958333 |
| 94 | MTOR | 0.68250284 |
| 95 | CSK | 0.67412752 |
| 96 | CDK15 | 0.67377652 |
| 97 | CSNK1A1L | 0.67165706 |
| 98 | WNK3 | 0.67060050 |
| 99 | PRKD1 | 0.66833260 |
| 100 | MAP3K8 | 0.66327906 |
| 101 | MAP3K2 | 0.65598094 |
| 102 | MAPK12 | 0.65485571 |
| 103 | MOS | 0.64989591 |
| 104 | ILK | 0.63970178 |
| 105 | GRK6 | 0.63803396 |
| 106 | JAK2 | 0.63318892 |
| 107 | RPS6KA2 | 0.63263498 |
| 108 | ERBB4 | 0.63104666 |
| 109 | MAPK4 | 0.62572084 |
| 110 | PRKCQ | 0.61757406 |
| 111 | LRRK2 | 0.61094574 |
| 112 | LIMK1 | 0.60947475 |
| 113 | BRSK1 | 0.60718311 |
| 114 | CDK14 | 0.60575798 |
| 115 | MATK | 0.60337774 |
| 116 | KIT | 0.60207571 |
| 117 | EPHA4 | 0.59172692 |
| 118 | ARAF | 0.58623923 |
| 119 | PRKD2 | 0.58146613 |
| 120 | CDK18 | 0.57419066 |
| 121 | CAMK1D | 0.56951633 |
| 122 | FGR | 0.56838056 |
| 123 | PRKAA2 | 0.56516938 |
| 124 | MAP3K9 | 0.55690747 |
| 125 | LMTK2 | 0.54880262 |
| 126 | PRKG2 | 0.53978541 |
| 127 | MAPK11 | 0.52272384 |
| 128 | CDK4 | 0.51839499 |
| 129 | PRKCH | 0.50583358 |
| 130 | ITK | 0.49435945 |
| 131 | ICK | 0.48918572 |
| 132 | GRK5 | 0.48744495 |
| 133 | IKBKB | 0.48336371 |
| 134 | IKBKE | 0.48164403 |
| 135 | DYRK1B | 0.47932560 |
| 136 | ROCK2 | 0.47415753 |
| 137 | RPS6KC1 | 0.46890144 |
| 138 | RPS6KL1 | 0.46890144 |
| 139 | MAPK7 | 0.46758416 |
| 140 | RIPK4 | 0.46247698 |
| 141 | CSNK1G2 | 0.45683156 |
| 142 | BMX | 0.44854739 |
| 143 | PTK2 | 0.44678055 |
| 144 | PRKACG | 0.44399374 |
| 145 | CAMKK1 | 0.44343768 |
| 146 | PDK1 | 0.43983861 |
| 147 | AKT2 | 0.43205935 |
| 148 | ZAP70 | 0.43052295 |
| 149 | STK38 | 0.43040048 |
| 150 | WNK1 | 0.42662601 |
| 151 | BLK | 0.42035104 |
| 152 | PKN2 | 0.41278246 |
| 153 | EPHA3 | 0.40848943 |
| 154 | MAP3K14 | 0.39972244 |
| 155 | PAK1 | 0.35484574 |
| 156 | EPHB2 | 0.34903148 |
| 157 | MAP2K6 | 0.34480093 |
| 158 | PAK6 | 0.31794281 |
| 159 | PRKCI | 0.26098996 |
| 160 | RPS6KA1 | 0.25475108 |
| 161 | CAMK1G | 0.24151084 |
| 162 | CDK9 | 0.22678276 |
| 163 | RPS6KB2 | 0.22601032 |
| 164 | RPS6KA6 | 0.21867686 |
| 165 | CSNK2A2 | 0.21410590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.48334298 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.94547437 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.72670254 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72609985 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.69961940 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48790826 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.48326378 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.47480659 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42393833 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34605946 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.32888350 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.31306107 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.29016492 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28993985 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.28461240 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.18863401 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.10744852 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05625131 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01791024 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.01122890 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99963499 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.98954610 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.91238087 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88194720 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77570800 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75450242 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.68458508 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67633544 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62641103 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.61404280 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51255869 |
| 32 | Ribosome_Homo sapiens_hsa03010 | 1.46857730 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42868869 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.40488016 |
| 35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.39023227 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36869349 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35543714 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33860591 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32428560 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.32051645 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31126613 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29605522 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.28875971 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26664933 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25996046 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24310884 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20128126 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.18019934 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17273571 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15840328 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14844294 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14200659 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.13508064 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10137664 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09511623 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03382945 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 1.03104469 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02949134 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.02317579 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01852507 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99457453 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96980528 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96323672 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95248378 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92607305 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89559755 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.87041371 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86109852 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85905461 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85571193 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84977833 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82921917 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.80283597 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.75722056 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69266247 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68887179 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68490790 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65991190 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65250426 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63893127 |
| 81 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.62607440 |
| 82 | Base excision repair_Homo sapiens_hsa03410 | 0.62391375 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62261132 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61332054 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60427513 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60246869 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59732796 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.55274059 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54727566 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54547702 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.51951134 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50301409 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45937362 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45735247 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43412806 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.42764284 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42091552 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41758412 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41104261 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40578154 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37417953 |
| 102 | DNA replication_Homo sapiens_hsa03030 | 0.36143286 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35750137 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.35683499 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35348850 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32758275 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.31800114 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.31577948 |
| 109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31237635 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30567491 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.30394779 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30015151 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.28786618 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.28438941 |
| 115 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.26474610 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26143516 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.24282743 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20994561 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.20062371 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18532766 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.14870362 |
| 122 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.14398563 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.11292513 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10586051 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.10055950 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.09166593 |
| 127 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.08385335 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.05283277 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.00327194 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0386464 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0358030 |
| 132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0319553 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0125046 |

